Ultralife Q2 revenue misses estimates

Ultralife

07/08/2025 12:25

Overview

Ultralife Q2 revenue rises 13% yr/yr to $48.6 mln, misses expectations

GAAP EPS for Q2 falls to $0.05, missing analyst estimates

Adjusted EBITDA declines to $4.1 mln, below expectations, due to tariffs and mix

Outlook

Ultralife expects Communications Systems business to rebound in second half 2025

Company anticipates early purchase orders from new battery product programs

Ultralife sees increased demand from medical and oil & gas sectors

Company expects sustained growth in global defense spending

Result Drivers

ELECTROCHEM IMPACT - Revenue increase driven by inclusion of Electrochem, offsetting flat organic sales in Battery & Energy Products

COMMUNICATIONS DECLINE - 57.2% drop in Communications Systems sales due to delayed purchase orders and prior year shipments

TARIFFS AND MIX - Gross margin affected by tariffs, unfavorable product mix, and lower factory throughput

Key Details

Metric
Beat/Miss
Actual
Consensus Estimate
Q2 Revenue
Miss
$48.56 mln
$51 mln (1 Analyst)
Q2 EPS
Miss
$0.05
$0.14 (1 Analyst)
Q2 Net Income
$870,000
Q2 Adjusted EBITDA
Miss
$4.11 mln
$5.60 mln (1 Analyst)
Q2 Operating Expenses
$9.34 mln
Q2 Operating Income
$2.26 mln
Q2 Pretax Profit
$1.11 mln


Analyst Coverage

The one available analyst rating on the shares is "buy"

The average consensus recommendation for the electrical components & equipment peer group is "buy"

Press Release: ID:nGNXf1g3q

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)